Comments
Commented by Tarik Dede on August 24th, 2026 | 08:15 CEST
Data as Currency in the AI Era: How Samsung Electronics, Aspermont and Siemens Stand to Benefit
AI language models have already made everyday tasks easier for millions of people. Quick research for work, or even checking the weather for leisure, is now often just a prompt away. But the real revolution is likely to take place in industry. Industrial companies have access to vast stores of historical data that can be leveraged not only to reduce costs, but also to increase revenue and profits. This transformation is already underway across a wide range of sectors, from automotive and aerospace to mining and semiconductor manufacturing. Today we take a closer look at the shares of Samsung Electronics, Aspermont and Siemens.
Read
Commented by Stefan Feulner on August 24th, 2026 | 08:10 CEST
IsoEnergy, Standard Uranium and Energy Fuels: 3 Uranium Stocks Poised for a Price Surge
Nuclear power is making a comeback worldwide. Rising electricity demand driven by AI data centers, the need for security of supply, and the desire for low-carbon baseload power are fueling new reactor projects. But this is bringing one bottleneck increasingly into focus: uranium. The World Nuclear Association expects demand to rise by 28% by 2030 and to more than double by 2040. At the same time, Western nations aim to reduce their dependence on problematic supply chains. Three companies are positioning themselves for this new uranium cycle.
Read
Commented by Tarik Dede on August 24th, 2026 | 08:05 CEST
Energy Market in Focus: 2G Energy, A.H.T. Syngas Technology and SFC Energy
The energy market is undergoing a major transformation. The oil age is not coming to an end, but alternative energy sources are gaining ground and filling the gaps left by a geopolitically chaotic world. Historically, oil and gas prices remain at elevated levels. For end consumers, however, the current situation is having devastating consequences in some cases. Extremely high diesel prices are weighing on commuters, travelers, and freight carriers. Expensive kerosene is taking a significant toll on airlines' bottom lines. And the outlook is not necessarily improving. The wars in the Middle East and in Ukraine, as well as tensions involving Russia, are causing supply disruptions on a scale rarely seen before. Some experts are even warning that the impact on oil could exceed that of the oil crises of the 1970s. Decentralized energy solutions offer one way to reduce these dependencies. Today, we therefore take a closer look at the shares of 2G Energy, A.H.T. Syngas Technology and SFC Energy.
Read
Commented by Armin Schulz on August 24th, 2026 | 08:00 CEST
Potential Winners of the USD 1.4 billion Pentagon Deal: Rheinmetall, HPQ Silicon and BYD
The Pentagon's USD 1.4 billion allocation to the US startup Sila Nanotechnologies for the development of silicon batteries is not a financial deal, but rather the starting signal for a new era in defense. The US military is aware that drones will dominate the battlefields of the future. Their performance is largely determined by the energy density of the battery cells. Silicon anodes promise advantages in terms of range and payload. The US and Europe have also recognized that they must reduce their dependence on Asian manufacturers for domestic supply chains. So today, we take a closer look at Rheinmetall's efforts, HPQ Silicon's latest innovations and BYD's battery activities.
Read
Commented by Nico Popp on August 24th, 2026 | 07:55 CEST
Government Debt Threatens Us All: Barrick Mining, Montage Gold and Hidden Gem Kobo Resources in Focus
As the debt spiral spins faster and faster and interest rates put entire nations under pressure, the time has come for tangible assets. Globally, a mountain of debt totaling over USD 350 billion is piling up—more than three times the total global economic output. As confidence in unbacked fiat currency wanes and even central banks turn to gold, retail investors are also seeking refuge in precious metals. We show that companies in the precious metals sector also offer opportunities and present three examples.
Read
Commented by Stefan Feulner on August 24th, 2026 | 07:50 CEST
Merck, Vidac Pharma, Moderna: New Cancer Treatments Send Stock Markets Soaring
A breakthrough in cancer research sent the stock market into a frenzy last week. For the first time, a personalized mRNA therapy has achieved key endpoints in a large Phase 3 trial, adding billions in market value within hours. At the same time, smaller biotech companies are working on entirely different approaches to target tumors at one of their greatest vulnerabilities. The race for the next generation of cancer treatments is thus gaining momentum. The economic potential is enormous.
Read
Commented by Fabian Lorenz on August 24th, 2026 | 07:45 CEST
Sell Rheinmetall? Evotec with AI Potential and Lahontan Gold's 22% Resource Boost!
Should investors sell Rheinmetall shares? That is the recommendation from mwb research. The analysts continue to view Rheinmetall as a clear operational winner in the European defense boom. However, they believe market expectations starting in 2028 are too ambitious. The company's order backlog is not as robust as many assume. By contrast, there are strong arguments for a rising share price at Lahontan Gold. The gold price climbed back above USD 4,600, suggesting that a new rally in the precious metal could be getting underway—the perfect timing to give the Lahontan story a boost. The company plans to build a mine and begin gold production next year. Most recently, the resource estimate was raised by 22%. And what about Evotec? Its stock is at rock bottom. Can AI-driven optimism provide new momentum?
Read
Commented by Nico Popp on August 24th, 2026 | 07:40 CEST
Robot Frenzy Surrounding Yushu Technology, SpaceX Rides the Starlink Wave, First Hydrogen Takes a Risk
When bold visions become reality, even the typically sober financial markets regularly go into a frenzy. The spectacular debut of Chinese robotics pioneer Yushu Technology on the Shanghai Stock Exchange has shown the market just how high a valuation premium forward-looking technology concepts can command. Whether it is bipedal machines, interplanetary spaceflight, or zero-emission freight transport: venture capitalists and individual investors reward companies that consciously blaze new trails. We introduce three such companies.
Read
Commented by Fabian Lorenz on August 24th, 2026 | 07:35 CEST
Share Price Surges and Buy Ratings: New Price Target for Almonty as CTS EVENTIM and BioNTech Stage Comebacks
What a comeback! Almonty's share price surged by more than 50% in August! There are good reasons for the rally. Tungsten is in short supply in the West and is urgently needed due to the ramp-up in weapons production in the US. In addition, Almonty has released convincing quarterly results and announced a share buyback program. Analysts have recently nearly doubled their price target. BioNTech's share price jump of over 25% is less attributable to the biotech company itself; the stock has benefited from the breakthrough achieved by rival Moderna. Meanwhile, long-term performer CTS EVENTIM also made a comeback last week. Does this mean the stock is returning to its long-term uptrend? Analysts recommend the share as a "Buy".
Read
Commented by Matthias Schomber on August 24th, 2026 | 07:30 CEST
Return Opportunities in Defence, Hydrogen and GreenTech: How Deutz, Nel ASA and MustGrow Biologics Are Gearing Up for a Breakout!
Created and Published on Behalf of MustGrow Biologics Corp.
Trump's hard-line stance in the Iran conflict and the blockade of the Strait of Hormuz have been keeping the financial markets on edge for weeks and months. This issue will likely remain with us for quite some time. However, these geopolitical crises are currently causing massive shifts in market weightings, with defence-related stocks gaining renewed momentum while many former "hydrogen hype" stocks continue to lose ground. Deutz AG, for example, is pivoting toward the defence technology sector with billion-euro acquisitions, thereby striking exactly the right chord with current market sentiment. Nel ASA, by contrast, is experiencing the opposite: despite a strong order book, weak margins continue to weigh on the stock. Away from these two companies, MustGrow Biologics, a smaller company operating in a niche market, is making headway. The Canadian agri-biotech specialist is making strides in sustainable crop protection and may be on the verge of a technical breakout.
Read